DNP_820___Case_Report.docx Benchmark- Case Report: Translational Research and Evidence-Based Practice Grand Canyon University: DNP-820 Introduction and Problem Statement Pain is a prevalent symptom experienced by
...
DNP_820___Case_Report.docx Benchmark- Case Report: Translational Research and Evidence-Based Practice Grand Canyon University: DNP-820 Introduction and Problem Statement Pain is a prevalent symptom experienced by cancer patients both during and after treatment. Unfortunately, there are several barriers that prevent cancer patients form receiving adequate pain control. Lack of pain management specialists, reluctance to prescribe opioids, and perceived regulatory constraints are often cited as barriers, but one of the most persistent barriers is inadequate provider knowledge regarding pain management (Scarborough & Smith, 2018, p. 195). Specifically, the barriers directly experienced by clinicians in relation to opioid prescriptions are; anxiety in relation to the regulation of control substances, concerns about the potential side effects of analgesics, and clinicians fear of patients developing tolerance or addiction to analgesics. Furthermore, clinicians often lack understanding of the common principles governing pain management; such as equianalgesic dose titration of opioids and unclear differences between physiologic dependence, pseudo-addiction, tolerance, and substance use disorder. For the purpose of this assignment, acase report will be presented to discuss inefficient pain management in outpatientsclinics due to physician related barriers. Synthesis of relevant evidence-based literature Several studies assessing barriers to adequate pain management in cancer patients identified physic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]